Jiuwei Cui
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 137
- Cancer Immunotherapy and Biomarkers 59
- Lung Cancer Research Studies 28
- CAR-T cell therapy research 22
-
- RNA modifications and cancer 21
- Co-authors
- Rilan Bai (26 shared papers)Ji‐Fan Hu (57 shared papers)Zheng Lv (13 shared papers)Chao Niu (30 shared papers)Naifei Chen (44 shared papers)Andrew R. Hoffman (35 shared papers)Dongsheng Xu (13 shared papers)Ling Bai (16 shared papers)
- Journals
- Journal of Clinical Oncology (30 papers)Annals of Oncology (14 papers)Frontiers in Oncology (13 papers)Frontiers in Immunology (11 papers)Oncotarget (10 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Jiuwei Cui
346 papers receiving 7.6k citations
Jiuwei Cui's Hit Papers
Peers
Comparison fields: 5 of 145
- Cancer Research 1.6k
- Oncology 2.2k
- Immunology 1.5k
- Molecular Biology 2.9k
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Jiuwei Cui
This map shows the geographic impact of Jiuwei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiuwei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiuwei Cui more than expected).
Fields of papers citing papers by Jiuwei Cui
This network shows the impact of papers produced by Jiuwei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiuwei Cui. The network helps show where Jiuwei Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiuwei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 358 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 333 | |
| 2 | Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors Hit paper breakdown → | 2020 | 328 |
| 3 | 2020 | 261 | |
| 4 | 2018 | 224 | |
| 5 | 2015 | 168 | |
| 6 | 2010 | 167 | |
| 7 | 2021 | 152 | |
| 8 | 2017 | 130 | |
| 9 | 2014 | 124 | |
| 10 | 2018 | 120 | |
| 11 | 2014 | 106 | |
| 12 | 2013 | 104 | |
| 13 | 2011 | 102 | |
| 14 | 2013 | 99 | |
| 15 | 2019 | 98 | |
| 16 | 2020 | 90 | |
| 17 | 2017 | 88 | |
| 18 | 2014 | 83 | |
| 19 | 2004 | 77 | |
| 20 | 2012 | 77 |
About Jiuwei Cui
Jiuwei Cui is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 358 papers that have together received 7.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (59 papers), Lung Cancer Treatments and Mutations (42 papers), Immune Cell Function and Interaction (39 papers), Lung Cancer Research Studies (28 papers), Nutrition and Health in Aging (26 papers), Cancer-related molecular mechanisms research (23 papers), CAR-T cell therapy research (22 papers) and RNA modifications and cancer (21 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.2k citations), Immunology (1.5k citations), Molecular Biology (2.9k citations) and Pulmonary and Respiratory Medicine (1.1k citations). Jiuwei Cui has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Rilan Bai, Ji‐Fan Hu, Zheng Lv, Chao Niu, Naifei Chen, Andrew R. Hoffman, Dongsheng Xu, Ling Bai, Yijing Zhao and Guanjun Wang. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Frontiers in Oncology, Frontiers in Immunology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.